Product Information
METHYLPHENIDATE ER 50 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $4.4474 per EA under NDC 00591389519. Its NADAC has been published 96 times since Apr 17, 2024.
FDA first approved this application on Dec 13, 2018. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591389519
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208861FDA Approved
12/13/2018
TE Code
AB3
On Market Since
9/30/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 50 MG CAP has been published 96 times since Apr 17, 2024, and over the history we have for it it has declined 24.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4474 per EA |
|---|---|
| All-time high | $5.8517 (Jun 12, 2024) |
| All-time low | $4.4409 (Aug 21, 2024) |
| 52-week high | $4.4474 |
| 52-week low | $4.4474 |
| Median price | $4.4474 |
| Average price | $4.7022 |
| Largest weekly change | -14.0% (Jul 17, 2024) |
| Weeks tracked | 96 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
-24.0%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 50 MG CAP, manufactured by Actavis Pharma, Inc., is $4.4474 per EA (NDC 00591389519), effective Feb 11, 2026.
How has the price of METHYLPHENIDATE ER 50 MG CAP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 50 MG CAP has declined 24.0%. It has been tracked across 96 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 50 MG CAP?
Since Apr 17, 2024, the NADAC for METHYLPHENIDATE ER 50 MG CAP has ranged from a low of $4.4409 (Aug 21, 2024) to a high of $5.8517 (Jun 12, 2024), with a median of $4.4474 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 50 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE CD 50 MG CAP, is $1.4616 per EA — about 67% below METHYLPHENIDATE ER 50 MG CAP.
Who manufactures METHYLPHENIDATE ER 50 MG CAP?
METHYLPHENIDATE ER 50 MG CAP (NDC 00591389519) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.